logo

For the Inventor, By the Inventor

Cambridge, United Kingdom

F-Star Therapeutics, Inc.


USPTO Granted Patents = 11



Trademarks = 2

Forward Citations = 50

Loading Chart...
Loading Chart...

33 inventors (with patents filed for the assignee):

goldMedal Mihriban Tuna (5 out of 14 patents)

silverMedal Radhakrishnan P Iyer (4 out of 38 patents)

bronzeMedal Francisca Wollerton Van Horck (3 out of 5 patents)

4.  Anjaneyulu Sheri (3 out of 6 patents)

5.  Geeta Meher (3 out of 5 patents)

6.  Shenghua Zhou (3 out of 9 patents)

7.  Sreerupa Challa (3 out of 7 patents)

8.  Katy Louise Everett (2 out of 4 patents)

9.  Miguel Gaspar (2 out of 6 patents)

10.  Katarzyna Kmiecik (2 out of 3 patents)

11.  Matthew Kraman (2 out of 3 patents)

12.  Natalie Fosh (2 out of 3 patents)

13.  Mustapha Faroudi (2 out of 3 patents)

14.  Florian Ruker (2 out of 13 patents)

15.  Gordana Wozniak-Knopp (2 out of 12 patents)


11 patents:

1. 12312408 - Multispecific anti-TCR delta variable 1 antibodies (2025-05-27),
2. 11827720 - Multivalent immunoglobulins (2023-11-28),
3. 11744845 - Compounds,compositions, and methods for the treatment of disease (2023-09-05),
4. 11707531 - Compounds, compositions, and methods for the treatment of disease (2023-07-25),
5. 11638716 - Compounds, compositions, and methods for the treatment of disease (2023-05-02),
6. 11629193 - EGFR binding molecules (2023-04-18),
7. 11584774 - Compounds, compositions, and methods for the treatment of disease (2023-02-21),
8. 11548948 - FC binding fragments comprising a PD-L1 antigen-binding site (2023-01-10),
9. 11499249 - Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions (2022-11-15),
10. 11214620 - Binding molecules binding PD-L1 and LAG-3 (2022-01-04),
11. 11214618 - LAG-3 binding members (2022-01-04),
Company Overview
F-Star Therapeutics, Inc. is a biopharmaceutical company based in Cambridge, UK, specializing in the development of innovative antibody therapeutics. The company focuses on its proprietary platform technology, which enables the creation of bispecific antibodies designed to target multiple pathways in disease processes. F-Star's research primarily centers on oncology and autoimmune disorders, aiming to enhance treatment efficacy and patient outcomes through advanced therapeutic modalities.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

11 Patents

#90 in Cambridge

#1,599 in United Kingdom

#51,761 in the World

Cambridge, GB
Cambridge, United Kingdom

F-Star Therapeutics, Inc.

Forward Citations = 50

33 inventors:

goldMedal Mihriban Tuna (5 out of 14 patents)

silverMedal Radhakrishnan P Iyer (4 out of 38 patents)

bronzeMedal Francisca Wollerton Van Horck (3 out of 5 patents)

4.  Anjaneyulu Sheri (3 out of 6 patents)

5.  Geeta Meher (3 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: F-Star Therapeutics, Inc.. Retrieved from https://idiyas.com/company/f-star-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…